CEACAM5 and gastric cancer: Further analysis showed that stage III GC patients with high pre- or postoperative levels of CEA, CA19-9 and CA72-4 trended to have lower RFS and OS, however, this difference was not significant in stage I and II GC patients (Fig. S).